Lina Zhang
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Cytopenias following anti-CD19 chimeric antigen receptor (CAR) T cell therapy: a systematic analysis for contributing factors.
Journal: Annals of medicine
Published: November 16, 2022
Baohuoside I Inhibits Tumor Angiogenesis in Multiple Myeloma via the Peroxisome Proliferator-Activated Receptor γ/Vascular Endothelial Growth Factor Signaling Pathway.
Journal: Frontiers in pharmacology
Published: November 25, 2021
Identification of clinical implications and potential prognostic models of chromatin regulator mutations in multiple myeloma.
Journal: Clinical epigenetics
Published: November 02, 2021
Comprehensive meta-analysis of anti-BCMA chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma.
Journal: Annals of medicine
Published: August 30, 2021
Etanercept as a new therapeutic option for cytokine release syndrome following chimeric antigen receptor T cell therapy.
Journal: Experimental hematology & oncology
Published: November 16, 2020
Anti-tumor activity of a novel proteasome inhibitor D395 against multiple myeloma and its lower cardiotoxicity compared with carfilzomib.
Journal: Cell death & disease
Published: October 26, 2020
Chimeric antigen receptor T cell therapies for multiple myeloma.
Journal: Journal of hematology & oncology
Published: August 07, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026